Biba lobbies Office of Fair Trading on PMI

Peter Staddon

The British Insurance Brokers' Association (Biba) has welcomed the Office of Fair Trading’s private healthcare scoping paper but urged it to address the activities of private medical insurance (PMI) companies.

Head of technical services at Biba Peter Staddon has called on the OFT to examine the duopoly of Bupa and Axa PPP as well as investigate the lack of claims data sharing in the PMI sector.

As a result of the trade body's formal response to the paper, the OFT has requested a meeting to discuss the matter further.

In a letter to the OFT Mr Staddon said: "As you have stated there is a duopoly operating in the market where over 65% of private medical insurance is written by only two insurance

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.

You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Age? View our subscription options

Register

Sign up and gain access to five complimentary news articles every month.

Already have an account? Sign in here

This address will be used to create your account

FCA warns on Tempcover clone

The Financial Conduct Authority has issued a warning of fraudsters trying to scam people by pretending to be short-term car insurance specialist broker Tempcover including on TikTok.

Brokers push for more from RSA/NIG

Brokers have given a mixed report on communication levels around the RSA and NIG deal but with the process kicking forwards today have expressed the hope the takeover will make more products available.

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: